02/14/2024
2:18 PM | ARCH Venture Fund IX, L.P. (Filed by)
Lyell Immunopharma (Subject)
| Form SC 13G/A | |
02/13/2024
7:22 PM | Lee Gary K. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:24 PM | Hill Stephen J. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:25 PM | Lang Matthew (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:17 PM | Lyell Immunopharma (Issuer)
Seely Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/13/2024
7:19 PM | Lyell Immunopharma (Issuer)
Newton Charles W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/29/2024
4:25 PM | BlackRock Inc. (Filed by)
Lyell Immunopharma (Subject)
| Form SC 13G | |
|
11/20/2023
7:53 PM | Lyell Immunopharma (Issuer)
Seely Lynn (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
7:54 PM | Lee Gary K. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
7:55 PM | Lyell Immunopharma (Issuer)
Newton Charles W. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
7:52 PM | Hill Stephen J. (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
3:26 PM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/07/2023
3:14 PM | Lyell Immunopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/11/2023
8:16 AM | Lyell Immunopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/08/2023
3:20 PM | Bishop Hans Edgar (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
3:22 PM | BRAWLEY OTIS W (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
3:23 PM | Lyell Immunopharma (Issuer)
NABEL ELIZABETH G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
3:24 PM | Lyell Immunopharma (Issuer)
NELSEN ROBERT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
3:26 PM | FRIEDMAN CATHY (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/08/2023
3:27 PM | Lyell Immunopharma (Issuer)
RIEFLIN WILLIAM JL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/17/2023
3:23 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/15/2023
2:04 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023
2:08 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023
2:16 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/15/2023
2:19 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/20/2023
12:07 PM | Lang Matthew (Reporting)
Lyell Immunopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
07/17/2023
4:42 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2023
4:47 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2023
4:32 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/17/2023
4:36 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Subject)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
06/20/2023
3:47 PM | Lyell Immunopharma (Issuer)
NABEL ELIZABETH G (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:49 PM | Lyell Immunopharma (Issuer)
NELSEN ROBERT (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:51 PM | Lyell Immunopharma (Issuer)
RIEFLIN WILLIAM JL (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:40 PM | Bishop Hans Edgar (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:41 PM | BRAWLEY OTIS W (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:43 PM | FRIEDMAN CATHY (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/20/2023
3:45 PM | Klausner Richard (Reporting)
Lyell Immunopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
